Cirrus Earplugs Looks To OTC Sleep Aids For Partnership
This article was originally published in The Tan Sheet
After becoming the leading seller of brand and private-label earplugs, Cirrus Healthcare Products’ further growth depends on expanding the market for its products. CEO Drew O’Connell says he is talking with OTC firms about co-marketing products, with OTC sleep aids as good potential candidates.
You may also be interested in...
While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
Trade group also compiled website with information and resources to help members "stay up to date and take any necessary steps to mitigate the risks associated with COVID-19." Its members also got a chance to describe potential supply chain disruptions in survey for USDA.